Walgreen Halts Genetic Test Kit Sale Post-FDA Warning

Law360, New York (May 13, 2010, 2:27 PM EDT) -- Walgreen Co. has elected to postpone its plans to be the first retailer to sell an over-the-counter personal genetic test kit manufactured by Pathway Genomics, following the U.S. Food and Drug Administration's warning that the product may lack sufficient regulatory clearance.

The retail pharmacy chain revealed its decision to halt the sale of the Pathway Genomics Insight Saliva Collection Kit on Wednesday, the same day the FDA publicly released a May 10 letter giving the San Diego-based genetic testing company 15 days to explain why it...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.